A disease registry study to prospectively observe treatment patterns and outcomes in patients with HER2-positive unresectable LA/MBC: final results of the ESTHER study

Ring, A., Sutherland, S., Harper-Wynne, C. et al. (3 more authors) (2025) A disease registry study to prospectively observe treatment patterns and outcomes in patients with HER2-positive unresectable LA/MBC: final results of the ESTHER study. Breast Cancer Research and Treatment, 212. pp. 113-121. ISSN 0167-6806

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s) 2025. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords: Metastatic, Breast, Cancer, HER2+, Registry, Non-interventional
Dates:
  • July 2025
  • Accepted: 22 April 2025
  • Published (online): 13 May 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 02 May 2025 12:46
Last Modified: 12 Jun 2025 12:01
Status: Published
Publisher: Springer Nature
Identification Number: 10.1007/s10549-025-07708-4
Open Archives Initiative ID (OAI ID):

Export

Statistics